OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
3.060
+0.430 (16.35%)
At close: Dec 5, 2025, 4:00 PM EST
2.880
-0.180 (-5.88%)
After-hours: Dec 5, 2025, 4:47 PM EST
OnKure Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 70.33 | 110.76 | 29.88 | 11.54 |
| Cash & Short-Term Investments | 70.33 | 110.76 | 29.88 | 11.54 |
| Cash Growth | 783.67% | 270.74% | 158.82% | - |
| Prepaid Expenses | 1.2 | 2.24 | 3.89 | 2.08 |
| Total Current Assets | 71.53 | 113 | 33.77 | 13.62 |
| Property, Plant & Equipment | 1.21 | 1.8 | 1.91 | 2.05 |
| Other Long-Term Assets | 0.1 | 0.11 | 0.06 | 0.33 |
| Accounts Payable | 1.29 | 2.97 | 3.42 | 2.52 |
| Accrued Expenses | 4.39 | 7.03 | 3.66 | 2.87 |
| Current Portion of Leases | 0.57 | 0.54 | 0.21 | 0.15 |
| Total Current Liabilities | 6.25 | 10.53 | 7.29 | 5.54 |
| Long-Term Leases | 0.12 | 0.55 | 0.47 | 0.49 |
| Common Stock | 0 | 0 | - | 0 |
| Additional Paid-In Capital | 267.17 | 258.55 | 0.21 | 2.66 |
| Retained Earnings | -200.74 | -154.72 | -102.05 | -57.07 |
| Total Common Equity | 66.43 | 103.83 | -101.84 | -54.42 |
| Total Liabilities & Equity | 72.84 | 114.91 | 35.73 | 16 |
| Total Debt | 0.69 | 1.09 | 0.67 | 0.64 |
| Net Cash (Debt) | 69.64 | 109.68 | 29.2 | 10.91 |
| Net Cash Growth | 4693.12% | 275.58% | 167.76% | - |
| Net Cash Per Share | 5.23 | 31.82 | 102.89 | - |
| Filing Date Shares Outstanding | 13.55 | 13.44 | 13.34 | - |
| Total Common Shares Outstanding | 13.55 | 13.35 | 13.34 | - |
| Working Capital | 65.28 | 102.47 | 26.48 | 8.08 |
| Book Value Per Share | 4.90 | 7.78 | -7.63 | - |
| Tangible Book Value | 66.43 | 103.83 | -101.84 | -54.42 |
| Tangible Book Value Per Share | 4.90 | 7.78 | -7.63 | - |
| Machinery | 0.99 | 1.05 | 1.01 | 0.85 |
| Leasehold Improvements | 1.09 | 1.09 | 1.09 | 1 |
Source: S&P Capital IQ. Standard template.
Financial Sources.